← Evidence map

ArticleVaccine2020

Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation.

Asimenia Angelidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

59 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32005538